Ashwagandha Advantage is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

An up-to-date review on ashwagandha clinical research studies with Chris Kilham - video

There is value in conducting multiple studies related to the same ingredient for the specified health conditions. Chris Kilham, a.k.a. “The Medicine Hunter” spoke with us at SupplySide West 2018 about four studies pending publication related to KSM-66 ashwagandha, and the process that drives credible publication.

Conducting clinical studies on an ingredient is a rigorous process that requires more than correct modeling, observable and measurable outcomes.  Credible studies require exhaustive peer review prior to publication, a process that bears no relationship to commercial outcomes.  Join us as Chris Kilham provides an early view at condition specific clinical studies on ashwagandha pending publication.

Hide comments
account-default-image

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish